Cite
HARVARD Citation
Forestieri, G. et al. (2022). Ibrutinib dose intensity in high‐risk chronic lymphocytic leukemia. Hematological oncology. 40 (5), pp. 1100-1104. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Forestieri, G. et al. (2022). Ibrutinib dose intensity in high‐risk chronic lymphocytic leukemia. Hematological oncology. 40 (5), pp. 1100-1104. [Online].